Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The C17orf58 pseudogene (ENSG00000261575) is classified as a pseudogene, meaning it is a genetic sequence with high similarity to a protein-coding gene but is not capable of encoding a functional protein product[1][3][4]. Pseudogenes can arise through duplication or retrotransposition but lack the necessary regulatory elements, intact open reading frames, or accumulated disabling mutations such as frameshifts or premature stop codons, hence do not produce proteins[3][5]. Most pseudogenes, including the C17orf58 pseudogene, do not have established biological functions or roles in disease, and they are not considered therapeutic targets such as receptors, enzymes, or transporters[1][3][5]. Some pseudogenes in general can have regulatory roles via noncoding RNA mechanisms or as microRNA decoys in select cases, but there is no evidence suggesting such a role for C17orf58 pseudogene[5]. Additional notes: - The C17orf58 gene (not the pseudogene) is a protein-coding gene and should not be confused with the pseudogene[2]. - This entry is marked as **not a therapeutic target** and should not be used as such. No drugs or mechanisms of action are associated with this pseudogene. - The query appears to refer to a *pseudogene* that lacks direct therapeutic significance; this is a common confusion when gene lists include both functional proteins and pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C17orf58 pseudogene.